You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華仁藥業(300110.SZ)子公司擬斥2000萬元設立西安藥聯通達 進一步加快醫藥產業生態圈業務佈局
格隆匯 01-08 17:14

格隆匯1月8日丨華仁藥業(300110.SZ)公佈,2020年1月6日,公司)第六屆董事會第十七次(臨時)會議審議通過《關於對外投資設立子公司的議案》,同意全資子公司西安華仁健康投資管理有限公司對外投資設立西安藥聯通達信息服務有限公司(暫定名,最終以工商行政管理部門核准為準),註冊資本2000萬元人民幣。

公司名稱:西安藥聯通達信息服務有限公司;經營範圍:互聯網信息服務、電子商務服務、諮詢服務、市場調研、健康信息諮詢服務、會務服務、會展服務、商務服務、醫療健康保健諮詢、家政服務、包裝服務、投資與資產管理、社會經濟諮詢、辦公服務、企業營銷策劃及管理諮詢、發佈國內各類廣告業務。

為進一步加快醫藥產業生態圈的業務佈局,發揮公司專業優勢,盤活現有資源,拓寬收入來源,公司全資子公司西安華仁健康投資管理有限公司擬設立西安藥聯通達信息服務有限公司(暫定名),為醫藥產業鏈上下游的醫藥研發、醫藥流通、醫藥服務、醫藥供應鏈金融等企業提供服務。

此次對外投資由公司以自有資金投入,對公司本年度的財務狀況和經營成果不會產生重大影響,不涉及關聯交易,不構成重大資產重組,不存在損害公司及其他股東合法利益的情形,從長遠來看對公司的持續、穩健發展有着積極的影響,符合全體股東的利益和公司長遠發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account